Polymer drug conjugates containing memantine, tacrine and cinnamic acid: promising nanotherapeutics for the treatment of Alzheimer’s disease

References

• Aderibigbe, B.A., et al., 2020. Polyamidoamine-drug conjugates containing metal-based anticancer compounds. Journal of inorganic and organometallic polymers and materials, 30 (5), 1503–1518.
   Web of Science ®Google Scholar
• Arisoy, S., et al., 2020. In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose-to-brain delivery. Pharmaceutical development and technology, 25 (6), 735–747. Taylor & Francis,
   PubMed Web of Science ®Google Scholar
• Arya, A., et al., 2021. Acetylcholinesterase inhibitory potential of various sesquiterpene analogues for Alzheimer’s disease therapy. Biomolecules, 11 (3), 350.
   PubMed Web of Science ®Google Scholar
• Badawi, N.M., et al., 2022. Investigating the impact of optimized trans -cinnamic acid-loaded plga nanoparticles on epithelial to mesenchymal transition in breast cancer. International journal of nanoscience, 17, 733–750.
   Google Scholar
• Breijyeh, Z., and Karaman, R., 2020. Comprehensive review on Alzheimer’s disease. Molecules, 25 (24), 5789.
   PubMed Web of Science ®Google Scholar
• Campos, V., et al., 2014. Characterization of neutrophil adhesion to different titanium surfaces. Bulletin of materials science, 37 (1), 157–166.
   Web of Science ®Google Scholar
• Cano, A., et al., 2021. Nanomedicine‑based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease : from current to future challenges. Journal of nanobiotechnology, 19 (1), 1–30.
   PubMed Web of Science ®Google Scholar
• Chen, T., et al., 2019. Nanoparticles mediating the sustained puerarin release facilitate improved brain delivery to treat parkinson’s disease. ACS applied materials & interfaces, 11 (48), 45276–45289.
   PubMed Web of Science ®Google Scholar
• Chen, Y., and Liu, L., 2012. Modern methods for delivery of drugs across the blood–brain barrier. Advanced drug delivery reviews, 64 (7), 640–665.
   PubMed Web of Science ®Google Scholar
• Dan, S., and Sharma, D., 2022. Therapeutic and diagnostic applications of nanocomposites in the treatment Alzheimer’s. Disease studies, 12 (1), 940–960.
   Google Scholar
• Danysz, W., and Parsons, C.G., 2003. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease: preclinical evidence. International journal of geriatric psychiatry, 18 (Suppl 1), S23–S32.
   PubMed Web of Science ®Google Scholar
• Dash, S., et al., 2010. Kinetic modeling on drug release from controlled drug delivery systems. Acta poloniae pharmaceutica, 67 (3), 217–223.
   PubMed Web of Science ®Google Scholar
• Da Silva-Candal, A., et al., 2019. Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions. Journal of controlled release: official journal of the controlled release society, 309, 94–105.
   PubMed Web of Science ®Google Scholar
• Duro-Castano, A., Movellan, J., and Vicent, M.J., 2015. Smart branched polymer-drug conjugates as nano-sized drug delivery systems. Biomaterials science, 3 (10), 1321–1334.
   PubMed Web of Science ®Google Scholar
• Fan, L., et al., 2019. New insights into the pathogenesis of Alzheimer’s disease. Frontiers in neurology, 10 (1312), 1312–1312.
   PubMed Web of Science ®Google Scholar
• Coué, G., and Engbersen, J.F., 2011. Functionalized linear poly (amidoamine)s are efficient vectors for intracellular protein delivery. Journal of controlled release, 152 (1), 90–98.
   PubMed Web of Science ®Google Scholar
• Gazova, Z., et al., 2017. Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer’s disease treatment. Biochimica et biophysica acta. Molecular basis of disease, 1863 (2), 607–619.
   PubMed Web of Science ®Google Scholar
• Ghafary, S., et al., 2020. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase. Daru : journal of faculty of pharmacy, Tehran University of medical sciences, 28 (2), 463–477.
   PubMed Web of Science ®Google Scholar
• Ghogari, I.S., and Jain, P.S., 2020. Original article development of orally disintegrating tablets Of memantine hydrochloride – A remedy for Alzheimer’s disease. International journal of applied pharmaceutics, 12 (1), 147–152.
   Google Scholar
• Haque, R.U., and Levey, A.I., 2019. Alzheimer’s disease : A clinical perspective and future nonhuman primate research opportunities. Proceedings of the national academy of sciences of the united states of america, 116 (52), 26224–26229.
   PubMed Web of Science ®Google Scholar
• Harkins, S.W., et al., 1997. Tacrine treatment in Alzheimer’s disease enhances cerebral blood flow and mental status and decreases caregiver suffering. Annals of the New York academy of sciences, 826 (1), 472–474.
   PubMedGoogle Scholar
• Heath, F., et al., 2016. A novel PEG-haloperidol conjugate with a non-degradable linker shows the feasibility of using polymer-drug conjugates in a non-prodrug fashion. Polymer chemistry, 7 (47), 7204–7210.
   Web of Science ®Google Scholar
• Hettiarachchi, S.D., et al., 2019. Nanoparticle-mediated approaches for Alzheimer’s disease pathogenesis, diagnosis, and therapeutics. Journal of controlled release : official journal of the controlled release society, 314, 125–140.
   PubMed Web of Science ®Google Scholar
• Jiang, X.Y., et al., 2018. Dual GSK-3β/AChE inhibitors as a new strategy for multitargeting anti-Alzheimer’s disease drug discovery. ACS medicinal chemistry letters, 9 (3), 171–176.
   PubMed Web of Science ®Google Scholar
• Kaniakova, M., et al., 2019. Combination of memantine and 6-chlorotacrine as novel multi-target compound against Alzheimer’s disease. Current Alzheimer research, 16 (9), 821–833.
   PubMed Web of Science ®Google Scholar
• Konda, R.K., et al., 2012. Bioanalytical method development and validation of memantine in human plasma by high performance liquid chromatography with tandem mass spectrometry : application to bioequivalence study. Journal of analytical methods in chemistry, 2012, 101248–101249.
   Web of Science ®Google Scholar
• Kos, J., et al., 2021. Trimethoxycinnamates and their cholinesterase inhibitory activity. Applied sciences, 11 (10), 4691.
   Google Scholar
• Kulkarni, S.A., and Feng, S.S., 2013. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharmaceutical research, 30 (10), 2512–2522.
   PubMed Web of Science ®Google Scholar
• Kumar, S.S., and Nadu, T., 2018. Formulation, characterization and determination of anti-Alzheimer activity of tacrine loaded poly (lactide-co-glycolide) nanoparticles. IJPSR, 9 (12), 5111–5120.
   Google Scholar
• Kuo, Y.C., and Rajesh, R., 2019. Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors. Expert review of neurotherapeutics, 19 (7), 623–652.
   PubMed Web of Science ®Google Scholar
• Lan, J.S., et al., 2017. Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer’s disease. Journal of enzyme inhibition and medicinal chemistry, 32 (1), 776–788.
   PubMed Web of Science ®Google Scholar
• Lee, J.H., and Kim, J.C., 2015. UV-absorbing and emulsifying property of cinnamic acid-conjugated gelatin. Journal of dispersion science and technology, 36 (7), 1000–1008.
   Web of Science ®Google Scholar
• Leis, H.J., and Windischhofer, W., 2012. Determination of memantine in human plasma by GC using negative ion chemical ionization MS detection after derivatization with a new reagent. Microchimica acta, 178 (3–4), 309–314.
   Web of Science ®Google Scholar
• Li, J., and Sabliov, C., 2013. PLA/PLGA nanoparticles for delivery of drugs across the blood–brain barrier. Nanotechnology reviews, 2 (3), 241–257.
   Web of Science ®Google Scholar
• Li, S.M., Mo, M.S., and Xu, P.Y., 2015. Progress in mechanisms of acetylcholinesterase inhibitors and memantine for the treatment of Alzheimer’s disease. Neuroimmunology and neuroinflammation, 2 (4), 274–280.
   Google Scholar
• Li, W., et al., 2016. Evaluation of antioxidant ability in vitro and bioavailability of trans-cinnamic acid nanoparticle by liquid antisolvent precipitate. Journal of nanomaterials, 2016, 1–11.
   Web of Science ®Google Scholar
• Li, X., Li, Q., and Zhao, C., 2021. Zero-order controlled release of water-soluble drugs using a marker pen platform. ACS omega, 6 (21), 13774–13778.
   PubMed Web of Science ®Google Scholar
• Lombardo, S.M., et al., 2020. Key for crossing the BBB with nanoparticles: the rational design. Beilstein journal of nanotechnology, 11 (866), 866–883.
   PubMed Web of Science ®Google Scholar
• Lv, L., et al., 2020. Brain-targeted co-delivery of β-amyloid converting enzyme 1 shRNA and epigallocatechin-3-gallate by multifunctional nanocarriers for Alzheimer’s disease treatment. IUBMB life, 72 (8), 1819–1829.
   PubMed Web of Science ®Google Scholar
• Mahmoudi, M., et al., 2021. Preparation and characterization of memantine-loaded polycaprolactone nanocapsules for Alzheimer’s disease. Journal of porous materials, 28 (1), 205–212.
   Web of Science ®Google Scholar
• Marcioni, M., et al., 2021. Semi-crystalline hydrophobic polyamidoamines: a new family of technological materials? Polymers, 13 (7), 1018.
   PubMed Web of Science ®Google Scholar
• Martin, Y.C., 2018. How medicinal chemists learned about log P. Journal of computer-aided molecular design, 32 (8), 809–819.
   PubMed Web of Science ®Google Scholar
• Martinez, M.A.F., et al., 2020. Surface roughness of titanium disks influences the adhesion, proliferation and differentiation of osteogenic properties derived from human. International journal of implant dentistry, 6 (1), 1–11.
   PubMed Web of Science ®Google Scholar
• Marucci, G., et al., 2021. Neuropharmacology efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology, 190, 108352(1–15).
   PubMed Web of Science ®Google Scholar
• Mehta, M., et al., 2012. New acetylcholinesterase inhibitors for Alzheimer’s disease. International journal of alzheimer disease, 2012, 1–8.
   Google Scholar
• Monge-Fuentes, V., et al., 2021. Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s disease. Scientific reports, 11 (1), 1–16.
   PubMed Web of Science ®Google Scholar
• Muntimadugu, E., et al., 2016. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer’s disease. European journal of pharmaceutical sciences : official journal of the European federation for pharmaceutical sciences, 92, 224–234.
   PubMed Web of Science ®Google Scholar
• Nikalje, A. P., 2015. Nanotechnology and its applications in medicine. In: W. Wang and S.A. Soper, eds. Bio-MEMS Technologies and Applications. CRC Press, Taylor and Francis Group, London, 81–89.
   Google Scholar
• Nordberg, A., 1996. Functional studies of new drugs for the treatment of Alzheimer’s disease. Acta neurologica Scandinavica, 94 (S165), 137–144.
   PubMed Web of Science ®Google Scholar
• Sharma, S., et al., 2020. Multi-spectroscopic monitoring of molecular ionic liquid and potential anti-Alzheimer’s drugs. RSC advances, 10 (64), 38873–38883.
   PubMed Web of Science ®Google Scholar
• Rajasekhar Reddy, A., et al., 2018. Effect of catalyst and solvent in synthesis of tacrine-terpenoid hybrid analogues : friedlander annulation approach. Journal of chemical and pharmaceutical sciences, 11 (04), 293–301.
   Google Scholar
• Lokhande, M.V., Kumar Gupta, M., and Rathod, N.G., 2013. Structural elucidation of process-related impurity in memantine hydrochloride bulk drug by GCMS, NMR and IR techniques. International journal of medicine and pharmaceutical sciences, 3 (3), 107–114.
   Google Scholar
• Ribovski, L., Hamelmann, N.M., and Paulusse, J.M.J., 2021. Polymeric nanoparticles properties and brain delivery. Pharmaceutics, 13 (12), 2045.
   PubMed Web of Science ®Google Scholar
• Romero, A., and Marco-Contelles, J., 2017. Recent developments on multi-target-directed tacrine for Alzheimer’s disease. I. The pyranotacrines. Current topics in medicinal chemistry, 17 (31), 3328–3335.
   PubMed Web of Science ®Google Scholar
• Romero, A., et al., 2013. Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer’s disease. Bioorganic & medicinal chemistry letters, 23 (7), 1916–1922.
   PubMed Web of Science ®Google Scholar
• Ríos, D.L., et al., 2019. Tacrines for Alzheimer’s disease therapy III. The pyridotacrines. European journal of medicinal chemistry, 166, 381–389.
   PubMed Web of Science ®Google Scholar
• Sadeghi, F., et al., 2020. Synthesis of a novel PEGylated colon-specific azo-based 4-aminosalicylic acid prodrug. Iranian journal of basic medical sciences, 23 (6), 781–787.
   PubMed Web of Science ®Google Scholar
• Sarathlal, K.C., et al., 2021. Exploring the neuroprotective potential of rosiglitazone embedded nanocarrier system on streptozotocin-induced mice model of Alzheimer’s disease. Neurotoxicity research, 39 (2), 240–255.
   PubMed Web of Science ®Google Scholar
• Silva-Abreu, M., et al., 2018. PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: In vitro and in vivo studies. International journal of nanomedicine, 13, 5577–5590.
   PubMed Web of Science ®Google Scholar
• Singh, A., et al., 2015. Preparation and characterization of rizatriptan benzoate loaded solid lipid nanoparticles for brain targeting. Materials today: proceedings, 2 (9), 4521–4543.
   Google Scholar
• Singh, A.P., et al., 2019. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal transduction and targeted therapy, 4 (1), 1–21.
   PubMed Web of Science ®Google Scholar
• Summers, W.K. Tacrine in the treatment of Alzheimer’s disease. https://jpands.org/hacienda/article31.html. (Accessed 18 May 2022).
   Google Scholar
• Sun, M., et al., 2017. Synthesis and characterization of hyperbranched poly(ester-amine) by Michael addition polymerization. Designed monomers and polymers, 20 (1), 458–467.
   PubMed Web of Science ®Google Scholar
• Tariot, P.N., et al., 2004. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. Journal of the American medical association, 291 (3), 317–324.
   PubMed Web of Science ®Google Scholar
• Machtakova, M., Thérien-Aubin, H., and Landfester, K., 2022. Polymer nano-systems for the encapsulation and delivery of active biomacromolecular therapeutic agents. Chemical society reviews, 51 (1), 128–152.
   PubMed Web of Science ®Google Scholar
• Vecchio, I., et al., 2021. The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease. Journal of Central nervous system disease, 13, 1–13.
   Web of Science ®Google Scholar
• Wu, I.Y., et al., 2019. Interpreting non-linear drug diffusion data: utilizing the Korsmeyer-Peppas model to study drug release from liposomes. European journal of pharmaceutical sciences : official journal of the European federation for pharmaceutical sciences, 138, 105026.
   PubMed Web of Science ®Google Scholar
• Youssif, K.A., et al., 2019. Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts. PLOS one, 14 (11), e0223781–19.
   PubMed Web of Science ®Google Scholar
• Zhang X., and Tian, Y., et al., 2021a. The epidemiology of Alzheimer’s disease modifiable risk factors and prevention. The journal of prevention of Alzheimer’s disease, 8 (3), 313–321.
   PubMed Web of Science ®Google Scholar
• Zhang, W., et al., 2021b. Carbon dots: a future blood–brain barrier penetrating nanomedicine and drug nanocarrier. International journal of nanomedicine, 16, 5003–5016.
   PubMed Web of Science ®Google Scholar
• Zeeshan, M., et al., 2019. Nanopharmaceuticals: a boon to the brain-targeted drug delivery’, in U. Ahmad, J. Akhtar (eds.), Pharmaceutical Formulation Design – Recent Practices, IntechOpen, London.
   Google Scholar
• Zhao, B., et al., 2019. Synthesis and characterization of novel porphyrin-cinnamic acid conjugates. Spectrochimica acta. Part A, molecular and biomolecular spectroscopy, 223, 117314.
   PubMed Web of Science ®Google Scholar